Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Cash from Financing Activities (2020 - 2025)

Pulse Biosciences has reported Cash from Financing Activities over the past 6 years, most recently at $381000.0 for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $381000.0 for Q4 2025, down 99.21% from a year ago — trailing twelve months through Dec 2025 was $17.2 million (down 84.43% YoY), and the annual figure for FY2025 was $17.2 million, down 84.43%.
  • Cash from Financing Activities for Q4 2025 was $381000.0 at Pulse Biosciences, down from $2.0 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for PLSE hit a ceiling of $65.1 million in Q3 2022 and a floor of -$549000.0 in Q4 2021.
  • Median Cash from Financing Activities over the past 5 years was $2.1 million (2023), compared with a mean of $15.1 million.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 19278.03% in 2021 and later crashed 564.62% in 2023.
  • Pulse Biosciences' Cash from Financing Activities stood at -$549000.0 in 2021, then surged by 96.9% to -$17000.0 in 2022, then soared by 4829.41% to $804000.0 in 2023, then skyrocketed by 5895.27% to $48.2 million in 2024, then tumbled by 99.21% to $381000.0 in 2025.
  • The last three reported values for Cash from Financing Activities were $381000.0 (Q4 2025), $2.0 million (Q3 2025), and $14.8 million (Q1 2025) per Business Quant data.